Isis Finds a Secure Port in the Storm
Executive Summary
Isis Pharmaceuticals has pursued antisense with a single-mindedness sharply contrasting to its two major California competitors, Gilead and Genta, who have each adopted theoretically nearer-term, strategies. Of the three, Isis is the alliance king, as its recent deal with Boehringer Ingelheim makes clear.